Endocrinologist Kevin M. Pantalone, DO, and psychiatrist Christian Kohler, MD, discuss the risk associated with the use of antipsychotic medications in individuals with type 2 diabetes.
Results reflect a higher clearance of small atherogenic very-low-density lipoproteins remnant particles, which might contribute to cardiovascular risk reduction beyond low-density lipoprotein cholesterol lowering in clinical routine.
Glucose screening during pregnancy can predict future cardiovascular (CV) risk in women with and without gestational diabetes, according to study results published in The Lancet Diabetes & Endocrinology. CV risk was found to be higher with abnormal glucose screening tests, but there was also increased CV risk in women with glucose concentrations at the upper…
Being a younger age at diagnosis of type 2 diabetes is associated with greater risk for total mortality and mortality related to cardiovascular disease outcomes.
Investigators examined the safety and lipid‐lowering efficacy of evolocumab combined with atorvastatin in patients with type 2 diabetes and hyperlipidemia or mixed dyslipidemia.
Objective short sleep duration is associated with daytime sleepiness, whereas obstructive sleep apnea is associated with obesity, dyslipidemia, and hypertension.
Colchicine is safe and effective at improving obesity-associated inflammatory measures among adults with obesity and metabolic syndrome without diabetes.
